EHC 2022 Archives - Medical Conferences

Home > Neurology > EHC 2022

Read the full Report (pdf)

European Headache Federation 07–10 December 2022 Vienna, Austria

EHF consensus on effective migraine treatment and triptan failure

Presented By

Prof. Uwe Reuter, Charité University Hospital of Berlin, Germany

Conference

EHC 2022

Type

News article

5 January 2023 11:31

IHS President: “It is time for operationalisation of ICHD”

Presented By

Prof. Cristina Tassorelli , University of Pavia, Italy

Conference

EHC 2022

Type

News article

5 January 2023 10:57

Online First

Headache Prophylaxis

Large gaps worldwide in prophylactic treatment of migraine

Trial

CaMEO-I

Conference

EHC 2022

Type

News article

5 January 2023 11:40

Atogepant for the preventive treatment of chronic migraine

Trial

Phase 3, PROGRESS

Conference

EHC 2022

Type

News article

5 January 2023 11:36

Intervention

EHF consensus on effective migraine treatment and triptan failure

Presented By

Prof. Uwe Reuter, Charité University Hospital of Berlin, Germany

Conference

EHC 2022

Type

News article

5 January 2023 11:31

Sustained long-term effect of occipital nerve stimulation in MICCH

Presented By

Dr Roemer Brandt, Leiden University Medical Centre, Netherlands

Trial

ICON

Conference

EHC 2022

Type

News article

5 January 2023 11:28

Onabotulinumtoxin A effective in older patients with chronic migraine

Presented By

Dr Raffaele Ornello , University of L’Aquila, Italy

Conference

EHC 2022

Type

News article

5 January 2023 11:23

Zavegepant nasal spray effective for the acute treatment of migraine

Presented By

Dr Robert Croop

Trial

Phase 3

Conference

EHC 2022

Type

News article

5 January 2023 11:15

What to do when conventional treatment of headache fails in children

Presented By

Prof. Ishaq Abu-Arafeh, Royal Hospital for Children, Glasgow, UK

Conference

EHC 2022

Type

News article

5 January 2023 11:12

Predicting response to medical and surgical treatment of trigeminal neuralgia

Presented By

Dr Joan Miquel Fernández-Vidal, Hospital de la Santa Creu i Sant Pau, Spa

Conference

EHC 2022

Type

News article

5 January 2023 11:05

Breakthroughs in Understanding Headache

IHS President: “It is time for operationalisation of ICHD”

Presented By

Prof. Cristina Tassorelli , University of Pavia, Italy

Conference

EHC 2022

Type

News article

5 January 2023 10:57

GWAS identifies 7 loci for cluster headache

Presented By

Dr Caroline Ran, Karolinska Institute, Sweden

Conference

EHC 2022

Type

News article

5 January 2023 10:31

Towards precision medicine: salivary CGRP and erenumab response

Presented By

Dr Alicia Alpuente, Vall d'Hebron University Hospital, Spain

Conference

EHC 2022

5 January 2023 10:28

Persistent headache after stroke: not rare and often overlooked

Presented By

Prof. Elena Lebedeva, Ural State Medical University, Russia

Conference

EHC 2022

Type

News article

5 January 2023 10:25

Additional effects of gepants on top of erenumab

Presented By

Dr Tessa de Vries, Erasmus Medical Center, the Netherlands

Conference

EHC 2022

Type

News article

5 January 2023 10:05

Headache Prevention

Idiopathic intracranial hypertension: key factors influencing visual outcomes

Presented By

Dr Mark Thaller, University of Birmingham, UK

Conference

EHC 2022

Type

News article

5 January 2023 12:55

Patients with migraines smoke less, drink less, and use fewer illicit drugs than general population

Presented By

Dr Thomas van den Hoek, Leiden University Medical Center, the Netherlands

Conference

EHC 2022

Type

News article

5 January 2023 11:43

Medical Conferences

EHC 2022

Featured articles

EHF consensus on effective migraine treatment and triptan failure

IHS President: “It is time for operationalisation of ICHD”

CONTENTS

Online First

Headache Prophylaxis

Large gaps worldwide in prophylactic treatment of migraine

Atogepant for the preventive treatment of chronic migraine

Intervention

EHF consensus on effective migraine treatment and triptan failure

Sustained long-term effect of occipital nerve stimulation in MICCH

Onabotulinumtoxin A effective in older patients with chronic migraine

Zavegepant nasal spray effective for the acute treatment of migraine

What to do when conventional treatment of headache fails in children

Predicting response to medical and surgical treatment of trigeminal neuralgia

Breakthroughs in Understanding Headache

IHS President: “It is time for operationalisation of ICHD”

GWAS identifies 7 loci for cluster headache

Towards precision medicine: salivary CGRP and erenumab response

Persistent headache after stroke: not rare and often overlooked

Additional effects of gepants on top of erenumab

Headache Prevention

Idiopathic intracranial hypertension: key factors influencing visual outcomes

Patients with migraines smoke less, drink less, and use fewer illicit drugs than general population